Kailera Therapeutics, Inc. (KLRA)

Price & Market Data

Price: $21.57

Daily Change: +$0.40 / 1.85%

Daily Range: $20.92 - $21.82

Market Cap: $2,794,119,680

Daily Volume: 484,307

Performance Metrics

1 Week: 0.62%

1 Month: -14.29%

3 Months: -20.11%

6 Months: -20.11%

1 Year: -20.11%

YTD: -20.11%

About Kailera Therapeutics, Inc. (KLRA)

Uncover the latest on Kailera Therapeutics, Inc. (KLRA). Trading at 21.57, the stock has shown a daily change of +$0.40 / 1.85%. With a market cap of 2,794,119,680, its performance over the last week (0.62%) and month (-14.29%) provides key insights.

Company Details

Employees: 145

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions. The company develops clinical- and preclinical-stage therapies, with a product pipeline that includes injectable peptides, oral peptides, and oral small molecules. Key programs include KAI-9531, an injectable GLP-1/GIP receptor dual agonist; KAI-7535, an oral small molecule GLP-1 receptor agonist; and KAI-4729, an injectable GLP-1/GIP/glucagon receptor tri-agonist. Kailera Therapeutics holds exclusive rights for global development and commercialization of four metabolic disease assets outside of Greater China, with therapies delivered through oral and injectable formulations. The company was founded in 2024 and is based in Waltham, Massachusetts.

Selected stocks

HMH Holding Inc. (HMH)

DAX Germany ETF (DAX)

RF Acquisition Corp II (RFAI)

BHAV Acquisition Corp (BHAV)

HawkEye 360, Inc. (HAWK)